Literature DB >> 21726166

Relationship between bilirubin and C-reactive protein.

Hee-Jin Hwang1, Sang-Woo Lee, Sang-Hwan Kim.   

Abstract

BACKGROUND: Epidemiologic studies have shown that serum total bilirubin is inversely related to an increased risk of coronary artery disease. However, the number of studies which have focused on the relationship between bilirubin and C-reactive protein (CRP), which is a marker reflecting chronic vascular inflammation, are limited.
METHOD: This cross-sectional study consisted of 2307 Korean adults who visited the Center for Health Promotion for a routine health check-up from January 2009 to December 2009. RESULT: CRP level showed a declining tendency as total bilirubin increased according to total bilirubin quartiles. Negative relations of CRP with both total and direct bilirubin were found after adjustment of age, body mass index, hypertension, diabetes, hypercholesterolemia, cardiovascular disease, taking aspirin, smoking, alcohol drinking and regular exercise and total bilirubin or direct bilirubin.
CONCLUSIONS: This study found that elevation of the two types of bilirubin (total and direct) have a relationship with a low serum CRP level among apparently healthy Korean adults. It is hypothesized that a low serum CRP level may be due to the antioxidant and anti-inflammatory effects of bilirubin metabolism.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21726166     DOI: 10.1515/CCLM.2011.662

Source DB:  PubMed          Journal:  Clin Chem Lab Med        ISSN: 1434-6621            Impact factor:   3.694


  19 in total

1.  Inverse association between serum total bilirubin levels and diabetic peripheral neuropathy in patients with type 2 diabetes.

Authors:  Eun Sook Kim; Sung Won Lee; Eun Young Mo; Sung Dae Moon; Je Ho Han
Journal:  Endocrine       Date:  2015-04-07       Impact factor: 3.633

2.  Serum bilirubin as a predictor of graft outcomes after renal transplant.

Authors:  Rayan Magsi; Neel Shetty; Zane Giffen; Barbara Saltzman; Nagalakshmi Nadiminty; Obi Ekwenna; Michael Rees; Puneet Sindhwani
Journal:  Am J Clin Exp Urol       Date:  2022-02-15

Review 3.  Heme oxygenase-1: a metabolic nike.

Authors:  Barbara Wegiel; Zsuzsanna Nemeth; Matheus Correa-Costa; Andrew C Bulmer; Leo E Otterbein
Journal:  Antioxid Redox Signal       Date:  2014-02-27       Impact factor: 8.401

4.  Prognostic value of serum bilirubin in patients with heart failure: A protocol for a systematic review and meta-analysis.

Authors:  Huan Wang; Qiulei Jia; Jingjing Shi; Yuanhui Hu
Journal:  Medicine (Baltimore)       Date:  2021-06-04       Impact factor: 1.817

5.  The role of bilirubin in diabetes, metabolic syndrome, and cardiovascular diseases.

Authors:  Libor Vítek
Journal:  Front Pharmacol       Date:  2012-04-03       Impact factor: 5.810

6.  Bile pigments in pulmonary and vascular disease.

Authors:  Stefan W Ryter
Journal:  Front Pharmacol       Date:  2012-03-08       Impact factor: 5.810

7.  Reduced circulating oxidized LDL is associated with hypocholesterolemia and enhanced thiol status in Gilbert syndrome.

Authors:  Ai-Ching Boon; Clare L Hawkins; Kavita Bisht; Jeff S Coombes; Bhavisha Bakrania; Karl-Heinz Wagner; Andrew C Bulmer
Journal:  Free Radic Biol Med       Date:  2012-04-14       Impact factor: 7.376

Review 8.  Low-normal thyroid function and novel cardiometabolic biomarkers.

Authors:  Lynnda J N van Tienhoven-Wind; Robin P F Dullaart
Journal:  Nutrients       Date:  2015-02-16       Impact factor: 5.717

9.  Body fat percentage is a major determinant of total bilirubin independently of UGT1A1*28 polymorphism in young obese.

Authors:  Luís Belo; Henrique Nascimento; Michaela Kohlova; Elsa Bronze-da-Rocha; João Fernandes; Elísio Costa; Cristina Catarino; Luísa Aires; Helena Ferreira Mansilha; Petronila Rocha-Pereira; Alexandre Quintanilha; Carla Rêgo; Alice Santos-Silva
Journal:  PLoS One       Date:  2014-06-05       Impact factor: 3.240

10.  High sensitive C-reactive protein and serum amyloid A are inversely related to serum bilirubin: effect-modification by metabolic syndrome.

Authors:  Petronella E Deetman; Stephan J L Bakker; Robin P F Dullaart
Journal:  Cardiovasc Diabetol       Date:  2013-11-09       Impact factor: 9.951

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.